Baiying Biotech sprints to the Shenzhen Stock Exchange: plans to raise 1.05 billion Gao Rong and Hangzhou Tigermed are shareholders

NoSuchKey

Guess you like

Origin blog.csdn.net/leijianping_ce/article/details/131820945